Logo image
The Evolving Biology of Microglia in Alzheimer's Disease
Journal article   Open access   Peer reviewed

The Evolving Biology of Microglia in Alzheimer's Disease

Tarja M. Malm, Taylor R. Jay and Gary E. Landreth
Neurotherapeutics, Vol.12(1), pp.81-93
01/01/2015
DOI: 10.1007/s13311-014-0316-8
PMCID: PMC4322081
PMID: 25404051
url
https://doi.org/10.1007/s13311-014-0316-8View
Published (Version of record) Open Access

Abstract

Alzheimer's disease (AD) is typified by a robust microglial-mediated inflammatory response within the brain. Indeed, microglial accumulation around plaques in AD is one of the classical hallmarks of the disease pathology. Although microglia have the capacity to remove beta-amyloid deposits and alleviate disease pathology, they fail to do so. Instead, they become chronically activated and promote inflammation-mediated impairment of cognition and cytotoxicity. However, if microglial function could be altered to engage their phagocytic response, promote their tissue maintenance functions, and prevent release of factors that promote tissue damage, this could provide therapeutic benefit. This review is focused on the current knowledge of microglial homeostatic mechanisms in AD, and mechanisms involved in the regulation of microglial phenotype in this context.
Clinical Neurology Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Pharmacology & Pharmacy Science & Technology

Details

Metrics

1 Record Views
Logo image